6Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in myocardial infarction(TIMI) trial, Phase I: A comparision between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation
7Sone T, Okumura K, Tsuboi H, et al. Angiographic no-flow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. JACC, 2000, 36:1202-1209.
8Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of ""no flow"" after percutaneous coronary intervention. Circulation, 1994,89:2514-2518.
9Abbo KM, Doris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol, 1995,75:778-782.
10Baumgent D, Haude M, Goerke G, et al. Improved assessment of coronary stenosis severity using the relative flow velocity reserve. Circulation, 1998,98:40-46.
1Patrick TO, Gara FGKD. 2013 ACCF/AHA Guideline for the manage- ment of ST-elevation myocardial infarction: executive summary[J]. J Am Coll Cardiol, 2013, 61 (4): 485-510.
2Huang D, Qian J, Ge L. Restoration of coronary flow in patients with no-reflow after primary coronary intervention of acute myocardial in- farction (RECOVER)[J]. Am Heart J, 2012, 164(3) :394-401.
3Ding S, Pu J, Qiao ZQ. TIMI myocardial perfusion frame count: a new method to assess myocardial perfusion and its predictive value for short-term prognosis[ J]. Catheter Cardiovasc Interv, 2010, 75 (5) : 722-732.
4Hiroshi I. The no-reflow phenomenon associated with pereutaneous coronary intervention: its mechanisms and treatment [ J]. Cardiovasc Interv and Ther, 2011, 26 ( 1 ) : 2-11.
